These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
638 related articles for article (PubMed ID: 24565767)
1. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization. Wong JT; Ling M; Patil S; Banerji A; Long A J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767 [TBL] [Abstract][Full Text] [Related]
2. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576 [TBL] [Abstract][Full Text] [Related]
3. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy. Wang AL; Patil SU; Long AA; Banerji A Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407 [TBL] [Abstract][Full Text] [Related]
4. Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy. Caiado J; Venemalm L; Pereira-Santos MC; Costa L; Barbosa MP; Castells M J Allergy Clin Immunol Pract; 2013; 1(5):494-500. PubMed ID: 24565621 [TBL] [Abstract][Full Text] [Related]
5. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions. Zhang X; Zhao Y; Zheng Y; Dong Y J Investig Allergol Clin Immunol; 2017; 27(1):65-66. PubMed ID: 28211349 [No Abstract] [Full Text] [Related]
6. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol. Gammon D; Bhargava P; McCormick MJ Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639 [TBL] [Abstract][Full Text] [Related]
7. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233 [TBL] [Abstract][Full Text] [Related]
8. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children. Hong DI; Dioun AF J Allergy Clin Immunol Pract; 2014; 2(1):13-9; quiz 20. PubMed ID: 24565764 [TBL] [Abstract][Full Text] [Related]
9. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization. Alvarez-Cuesta E; Madrigal-Burgaleta R; Angel-Pereira D; Ureña-Tavera A; Zamora-Verduga M; Lopez-Gonzalez P; Berges-Gimeno MP Allergy; 2015 Jul; 70(7):784-94. PubMed ID: 25832325 [TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. Meyer L; Zuberbier T; Worm M; Oettle H; Riess H J Clin Oncol; 2002 Feb; 20(4):1146-7. PubMed ID: 11844841 [No Abstract] [Full Text] [Related]
11. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol. Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137 [TBL] [Abstract][Full Text] [Related]
12. Skin test protocol for the prevention of hypersensitivity reactions to oxaliplatin. Pagani M; Bonadonna P Anticancer Res; 2014 Jan; 34(1):537-40. PubMed ID: 24403513 [TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492 [TBL] [Abstract][Full Text] [Related]
14. Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms. Wong JT; Long A J Allergy Clin Immunol Pract; 2017; 5(6):1564-1571. PubMed ID: 29122155 [TBL] [Abstract][Full Text] [Related]
15. Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposure. Lee SY; Kang HR; Song WJ; Lee KH; Han SW; Cho SH Cancer Chemother Pharmacol; 2014 May; 73(5):1021-9. PubMed ID: 24696124 [TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions. Kuo JC; Hawkins C; Yip D Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214 [TBL] [Abstract][Full Text] [Related]
17. Desensitization with oxaliplatin in patients intolerant of carboplatin desensitization. Rose PG; Metz C; Link N Int J Gynecol Cancer; 2014 Nov; 24(9):1603-6. PubMed ID: 25304679 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin. Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675 [TBL] [Abstract][Full Text] [Related]
19. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin. Pagani M; Bonadonna P; Senna GE; Antico A Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101 [TBL] [Abstract][Full Text] [Related]
20. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Lee CW; Matulonis UA; Castells MC Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]